Loading clinical trials...
Loading clinical trials...
Phase 2 Study of High Risk Prostatae Cancer Treated With Dose-escalated Simultaneous Integrated Boost to Prostate and Lymph Node GTV
Conditions
Interventions
SIB Dose-Escalation Radiotherapy
Locations
1
Sweden
Umeå University, Cancercenter
Umeå, Sweden
Start Date
March 1, 2015
Primary Completion Date
May 9, 2023
Completion Date
May 9, 2023
Last Updated
March 1, 2024
NCT07225946
NCT04868604
NCT00756665
NCT05743621
NCT04104776
NCT06242119
Lead Sponsor
Umeå University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions